Antibody Characterization Report for PATL2

This article presents characterization data that can be utilized as a guide to select high-performing antibodies for Protein PAT1 homolog 2 (PATL2), encoded by the PATL2 gene. Six commercial and custom-made antibodies were evaluated in western blot and immunoprecipitation experiments using a standardized protocol that compares readouts in isogenic parental controls and knockout cell lines. A human PATL2 construct in the pcDNA3-1(+) vector (cloned at GenScript) was obtained to overexpress the protein. This study will be revisited, and immunofluorescence will be performed once additonal custom recombinant antibodies are available on commercial catalogs. Thank you to the Bill and Melinda Gates Foundation for their support and nomination of this target as well as the Structural Genomics Consortium for coordinating this study.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-30
DOI
https://doi.org/10.5281/zenodo.13618082
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibody Characterization Report for PATL2

Zenodo (CERN European Organization for Nuclear Research)
Monoclonal and Polyclonal Antibodies Research
article

Antibody Characterization Report for PATL2

article en

Abstract

This article presents characterization data that can be utilized as a guide to select high-performing antibodies for Protein PAT1 homolog 2 (PATL2), encoded by the PATL2 gene. Six commercial and custom-made antibodies were evaluated in western blot and immunoprecipitation experiments using a standardized protocol that compares readouts in isogenic parental controls and knockout cell lines. A human PATL2 construct in the pcDNA3-1(+) vector (cloned at GenScript) was obtained to overexpress the protein. This study will be revisited, and immunofluorescence will be performed once additonal custom recombinant antibodies are available on commercial catalogs. Thank you to the Bill and Melinda Gates Foundation for their support and nomination of this target as well as the Structural Genomics Consortium for coordinating this study.

Zenodo (CERN European Organization for Nuclear Research)
Montreal Neurological Institute and Hospital (CA), University of Toronto (CA), McGill University (CA)
Openalex Percentile: Top 53%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.